Lymphogranuloma	Lymphogranuloma	NN	B-NP	O	
venereum	venereum	NN	I-NP	O	
presenting	present	VBG	B-VP	O	
as	as	IN	B-SBAR	O	
perianal	perianal	JJ	B-NP	O	
ulceration	ulceration	NN	I-NP	O	
:	:	:	O	O	
an	an	DT	B-NP	O	
emerging	emerge	VBG	I-NP	O	
clinical	clinical	JJ	I-NP	O	
presentation	presentation	NN	I-NP	O	
?	?	.	O	O	

An	An	DT	B-NP	O	
outbreak	outbreak	NN	I-NP	O	
of	of	IN	B-PP	O	
lymphogranuloma	lymphogranuloma	NN	B-NP	O	
venereum	venereum	NN	I-NP	O	
(	(	(	O	O	
LGV	LGV	NN	B-NP	O	
)	)	)	O	O	
infection	infection	NN	B-NP	O	
has	have	VBZ	B-VP	O	
been	be	VBN	I-VP	O	
recognised	recognise	VBN	I-VP	O	
in	in	IN	B-PP	O	
the	the	DT	B-NP	O	
UK	UK	NN	I-NP	O	
since	since	IN	B-PP	O	
2004	2004	CD	B-NP	O	
,	,	,	O	O	
predominantly	predominantly	RB	B-VP	O	
affecting	affect	VBG	I-VP	O	
HIV	HIV	NN	B-NP	O	
-	-	HYPH	I-NP	O	
positive	positive	JJ	I-NP	O	
men	man	NNS	I-NP	O	
who	who	WP	B-NP	O	
have	have	VBP	B-VP	O	
sex	sex	NN	B-NP	O	
with	with	IN	B-PP	O	
men	man	NNS	B-NP	O	
(	(	(	O	O	
MSM	MSM	NN	B-NP	B-protein	
)	)	)	O	O	
.	.	.	O	O	

Patients	Patient	NNS	B-NP	O	
typically	typically	RB	B-ADVP	O	
present	present	VBP	B-VP	O	
with	with	IN	B-PP	O	
proctitis	proctitis	NN	B-NP	O	
symptoms	symptom	NNS	I-NP	O	
.	.	.	O	O	

The	The	DT	B-NP	O	
prevalence	prevalence	NN	I-NP	O	
of	of	IN	B-PP	O	
rectal	rectal	JJ	B-NP	O	
LGV	LGV	NN	I-NP	O	
in	in	IN	B-PP	O	
MSM	MSM	NN	B-NP	O	
attending	attend	VBG	B-VP	O	
sexually	sexually	RB	B-NP	O	
transmitted	transmit	VBN	I-NP	O	
infection	infection	NN	I-NP	O	
clinics	clinic	NNS	I-NP	O	
in	in	IN	B-PP	O	
London	London	NNP	B-NP	O	
is	be	VBZ	B-VP	O	
estimated	estimate	VBN	I-VP	O	
at	at	IN	B-PP	O	
1%	1%	NN	B-NP	O	
.	.	.	O	O	

Health	Health	NNP	B-NP	O	
Protection	Protection	NNP	I-NP	O	
Agency	Agency	NNP	I-NP	O	
surveillance	surveillance	NN	I-NP	O	
has	have	VBZ	B-VP	O	
shown	show	VBN	I-VP	O	
a	a	DT	B-NP	O	
decrease	decrease	NN	I-NP	O	
in	in	IN	B-PP	O	
anorectal	anorectal	JJ	B-NP	O	
manifestations	manifestation	NNS	I-NP	O	
despite	despite	IN	B-PP	O	
little	little	JJ	B-NP	O	
demographic	demographic	JJ	I-NP	O	
change	change	NN	I-NP	O	
.	.	.	O	O	

Two	Two	CD	B-NP	O	
cases	case	NNS	I-NP	O	
of	of	IN	B-PP	O	
HIV	HIV	NN	B-NP	O	
-	-	HYPH	B-NP	O	
infected	infect	VBN	I-NP	O	
patients	patient	NNS	I-NP	O	
presenting	present	VBG	B-VP	O	
with	with	IN	B-PP	O	
isolated	isolate	VBN	B-NP	O	
perianal	perianal	JJ	I-NP	O	
ulcer	ulcer	NN	I-NP	O	
disease	disease	NN	I-NP	O	
are	be	VBP	B-VP	O	
reported	report	VBN	I-VP	O	
here	here	RB	B-ADVP	O	
.	.	.	O	O	

Both	Both	DT	B-NP	O	
cases	case	NNS	I-NP	O	
were	be	VBD	B-VP	O	
confirmed	confirm	VBN	I-VP	O	
to	to	TO	I-VP	O	
have	have	VB	I-VP	O	
rectal	rectal	JJ	B-NP	O	
Chlamydia trachomatis	Chlamydia_trachomatis	NN	I-NP	O	
-	-	HYPH	B-NP	O	
specific	specific	JJ	I-NP	O	
DNA	DNA	NN	I-NP	O	
of	of	IN	B-PP	O	
an	an	DT	B-NP	O	
LGV	LGV	NN	I-NP	B-protein	
associated	associated	JJ	I-NP	I-protein	
serovar	serovar	NN	I-NP	I-protein	
.	.	.	O	O	

As	As	IN	B-SBAR	O	
presentations	presentation	NNS	B-NP	O	
of	of	IN	B-PP	O	
LGV	LGV	NN	B-NP	B-protein	
diversify	diversify	VBP	B-VP	O	
,	,	,	O	O	
further	further	JJ	B-NP	O	
education	education	NN	I-NP	O	
and	and	CC	I-NP	O	
surveillance	surveillance	NN	I-NP	O	
are	be	VBP	B-VP	O	
needed	need	VBN	I-VP	O	
in	in	IN	B-SBAR	O	
order	order	NN	O	O	
to	to	TO	B-VP	O	
reduce	reduce	VB	I-VP	O	
transmission	transmission	NN	B-NP	O	
and	and	CC	O	O	
prevent	prevent	VBP	B-VP	O	
long	long	JJ	B-NP	O	
-	-	HYPH	I-NP	O	
term	term	NN	I-NP	O	
complications	complication	NNS	I-NP	O	
.	.	.	O	O	

A	A	DT	B-NP	O	
strong	strong	JJ	I-NP	O	
argument	argument	NN	I-NP	O	
already	already	RB	B-ADVP	O	
exists	exist	VBZ	B-VP	O	
for	for	IN	B-PP	O	
the	the	DT	B-NP	O	
incorporation	incorporation	NN	I-NP	O	
of	of	IN	B-PP	O	
chlamydia	chlamydia	NN	B-NP	O	
nucleic	nucleic	JJ	I-NP	O	
acid	acid	NN	I-NP	O	
amplification	amplification	NN	I-NP	O	
tests	test	NNS	I-NP	O	
in	in	IN	B-PP	O	
the	the	DT	B-NP	O	
management	management	NN	I-NP	O	
of	of	IN	B-PP	O	
MSM	MSM	NN	B-NP	B-protein	
with	with	IN	B-PP	O	
proctitis	proctitis	NN	B-NP	O	
;	;	:	O	O	
this	this	DT	B-NP	O	
paper	paper	NN	I-NP	O	
provides	provide	VBZ	B-VP	O	
evidence	evidence	NN	B-NP	O	
that	that	IN	B-SBAR	O	
this	this	DT	B-NP	O	
should	should	MD	B-VP	O	
be	be	VB	I-VP	O	
extended	extend	VBN	I-VP	O	
to	to	TO	B-PP	O	
MSM	MSM	NN	B-NP	B-protein	
with	with	IN	B-PP	O	
perianal	perianal	JJ	B-NP	O	
ulcer	ulcer	NN	I-NP	O	
disease	disease	NN	I-NP	O	
.	.	.	O	O	

